Liaoning He Eye Hospital Group Co. LTD.
Liaoning He Eye Hospital Group Co., LTD. provides ophthalmic specialist diagnosis, treatment, and optometry services to patients with eye diseases. It offers cataract diagnosis and treatment, refractive error surgical correction, vitreoretinal diagnosis and treatment, other surgical diagnosis and treatment services, etc. The company also provides refractive cataracts, LASIK surgery, myopia preven… Read more
Market Cap & Net Worth: Liaoning He Eye Hospital Group Co. LTD. (301103)
Liaoning He Eye Hospital Group Co. LTD. (SHE:301103) has a market capitalization of $445.18 Million (CN¥3.27 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #16168 globally and #4295 in its home market, demonstrating a -1.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Liaoning He Eye Hospital Group Co. LTD.'s stock price CN¥20.67 by its total outstanding shares 158026471 (158.03 Million).
Liaoning He Eye Hospital Group Co. LTD. Market Cap History: 2022 to 2026
Liaoning He Eye Hospital Group Co. LTD.'s market capitalization history from 2022 to 2026. Data shows change from $644.78 Million to $445.18 Million (-12.68% CAGR).
Liaoning He Eye Hospital Group Co. LTD. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Liaoning He Eye Hospital Group Co. LTD.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.40x
Liaoning He Eye Hospital Group Co. LTD.'s market cap is 0.40 times its annual revenue
0.38x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $644.78 Million | $955.31 Million | $32.59 Million | 0.67x | 19.78x |
| 2023 | $627.67 Million | $1.19 Billion | $63.55 Million | 0.53x | 9.88x |
| 2024 | $433.34 Million | $1.10 Billion | -$27.40 Million | 0.40x | N/A |
Competitor Companies of 301103 by Market Capitalization
Companies near Liaoning He Eye Hospital Group Co. LTD. in the global market cap rankings as of March 18, 2026.
Key companies related to Liaoning He Eye Hospital Group Co. LTD. by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #271 globally with a market cap of $77.08 Billion USD.
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1068 globally with a market cap of $18.32 Billion USD.
- Fresenius SE & Co. KGaA (PINK:FSNUF): Ranked #1139 globally with a market cap of $16.86 Billion USD.
- Brookdale Senior Living Inc (NYSE:BKDT): Ranked #1227 globally with a market cap of $15.19 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | HCA Holdings Inc | NYSE:HCA | $77.08 Billion | $509.87 |
| #1068 | Tenet Healthcare Corporation | NYSE:THC | $18.32 Billion | $211.64 |
| #1139 | Fresenius SE & Co. KGaA | PINK:FSNUF | $16.86 Billion | $41.01 |
| #1227 | Brookdale Senior Living Inc | NYSE:BKDT | $15.19 Billion | $77.60 |
Liaoning He Eye Hospital Group Co. LTD. Historical Marketcap From 2022 to 2026
Between 2022 and today, Liaoning He Eye Hospital Group Co. LTD.'s market cap moved from $644.78 Million to $ 445.18 Million, with a yearly change of -12.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥445.18 Million | +5.35% |
| 2025 | CN¥422.57 Million | -2.49% |
| 2024 | CN¥433.34 Million | -30.96% |
| 2023 | CN¥627.67 Million | -2.65% |
| 2022 | CN¥644.78 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Liaoning He Eye Hospital Group Co. LTD. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $445.18 Million USD |
| MoneyControl | $445.18 Million USD |
| MarketWatch | $445.18 Million USD |
| marketcap.company | $445.18 Million USD |
| Reuters | $445.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.